Zocor Lawsuit News | Zocor Lawsuit Center

TV Advertising Promotes Unnecessary Statin Use, Says Study

Neal Donaghy | September 16th, 2013
ZOCOR Side Effects

Aggressive marketing tactics for Zocor, Lipitor and other cholesterol drugs are prompting low-risk individuals to take them unnecessarily, and exposing themselves to potentially serious statin side effects, according to a recent study. The research also suggests that such advertising actually deters individuals at a higher risk of heart disease from taking the products. The research reviewed the effect on viewers… Read more »

New Statin Study Finds Greater Likelihood of Zocor Muscle Injury

Nathaniel Zimmerman | July 7th, 2013
ZOCOR Muscle Injury

A new study on statins published in the American Medical Association’s JAMA Internal Medicine journal finds that the popular anti-cholesterol drugs are associated with an elevated likelihood of musculoskeletal adverse events, especially in patients who are physically active. Patients in the study who were taking medications like Lipitor, Crestor, and Zocor were more likely than similar patients not taking statins… Read more »

Benefits of Exercise Hampered by Zocor, Study Says

Ava Lawson | June 7th, 2013
ZOCOR Muscle Injury Lawsuit

Patients with high levels of cholesterol, particularly low-density lipoproteins (LDL), are often prescribed statin drugs and a routine of cardiovascular exercise to help combat negative effects and lower lipid profiles to a healthy level. However, new research shows that simvastatin-containing medications such as Zocor may decrease the overall benefits of exercise, leaving patients with an impaired ability to improve both… Read more »

Zocor Side Effects Include Kidney Damage, According to New Research

Neal Donaghy | May 10th, 2013
Zocor Liver Damage

In a new study published by the British Medical Journal, researchers claim that cholesterol medications including Zocor, Lipitor and Crestor may increase the risk of kidney damage. A Canadian research team found that the high-potency statins resulted in a 34% increase in the likelihood of hospitalization for acute kidney injuries. The news comes after a 2011 FDA-imposed dosage restriction that… Read more »

Review of FDA Zocor Warnings

Shay Morrigan | February 12th, 2013
ZOCOR FDA Warning 80mg

The FDA approved Zocor (simvastatin) as a cholesterol lowering statin in 1991. The medication is available in 5, 10, 20, 40, and 80 mg tablets. In the years since its launch, the drug has been linked with serious Zocor side effects like muscle weakness and pain, muscle wasting, and kidney failure. Though there has been no Zocor recall, the FDA… Read more »